Isura
8
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Pharmacokinetics and Safety of a New Micellar Glutathione Formulation
Role: collaborator
Chrysin Bioavailability and Safety
Role: lead
Glucosamine Sulfate Bioavailability
Role: lead
Safety and Bioavailability of Micellar Green Tea Extract
Role: lead
Silymarin Bioavailability Study
Role: lead
Safety Profile of a New Berberine Formulation with Improved Bioavailability
Role: lead
Metabolic Differences Between Dihydroberberine and Micellar Berberine
Role: collaborator
Pharmacokinetics of Different CoQ10 Formulations
Role: collaborator
All 8 trials loaded